The clinical utility of polygenic risk scores in genomic medicine practices: A systematic review
Genomic medicine aims to improve health using the individual genomic data of people to inform care. While clinical utility of genomic medicine in many monogenic, Mendelian disorders is amply demonstrated, clinical utility is less evident in polygenic traits, e.g., coronary artery disease or breast c...
Saved in:
Main Authors: | Kumuthini, Judit, Zick, Brittany, Balasopoulou, Angeliki, Chalikiopoulou, Constantina, Dandara, Collet, El-Kamah, Ghada, Findley, Laura, Katsila, Theodora, Li, Rongling, Bon Maceda, Ebner, Monye, Henrietta, Rada, Gabriel, Thong, Meow-Keong, Wanigasekera, Thilina, Kennel, Hannah, Marimuthu, Veeramani, Williams, Marc S., Al-Mulla, Fahd, Abramowicz, Marc, Investigators, G2MC Evidence |
---|---|
Format: | Article |
Published: |
Springer
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/41252/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polygenic testing for IVF embryo selection in Singapore: proceed with caution
by: Chin, Alexis Heng Boon, et al.
Published: (2024) -
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
by: Huynh-Le, Minh-Phuong, et al.
Published: (2021) -
Polygenic risk scores for prediction of breast cancer risk in Asian populations
by: Ho, Weang-Kee, et al.
Published: (2022) -
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
by: Karunamuni, Roshan A., et al.
Published: (2021) -
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score
by: Huynh-Le, Minh-Phuong, et al.
Published: (2022)